The Heart of the World.

Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, McGhie DV, Mwangi J, Pervan B, Narula J, Pineiro D, Pinto FJ. · 2024

Read The Heart of the World. by Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, McGhie DV, Mwangi J, Pervan B, Narula J, Pineiro D, Pinto FJ. (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10809869.txt.

Introduction

Di Cesare and colleagues give a global snapshot of heart and vessel disease in this 2024 paper. Cardiovascular diseases, meaning diseases of the heart and blood vessels, are the top cause of death worldwide. Of 20.5 million such deaths in 2021, about 80 percent were in low- and middle-income countries. The authors pull together the burden, the risk factors, health spending, and policy action by region.

High blood pressure stands out as the leading risk factor, tied to 10.8 million deaths in 2019, they report. Death rates are highest in Central and Eastern Europe and Central Asia. Policy scores vary widely, with parts of Africa scoring lowest. The authors urge each country to study its own risk profile. They back core steps such as tobacco control, steady access to heart drugs, and units in health ministries for these diseases.

Catalog record

CREATORDi Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, McGhie DV, Mwangi J, Pervan B, Narula J, Pineiro D, Pinto FJ.
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10809869

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Heart of the World By Mariachiara Di Cesare, Pablo Perel, Sean Taylor, Chodziwadziwa Kabudula, Honor Bixby, Thomas A. Gaziano, Diana Vaca McGhie, Jeremiah Mwangi, Borjana Pervan, Jagat Narula, Daniel Pineiro, Fausto J. Pinto Published in: Global Heart DOI: 10.5334/gh.1288 ABSTRACT Cardiovascular diseases (CVDs) are the leading cause of mortality globally. Of the 20.5 million CVD-related deaths in 2021, approximately 80% occurred in low- and middle-income countries. Using data from the Global Burden of Disease Study, NCD Risk Factor Collaboration, NCD Countdown initiative, WHO Global Health Observatory, and WHO Global Health Expenditure database, we present the burden of CVDs, associated risk factors, their association with national health expenditures, and an index of critical policy implementation. The Central Europe, Eastern Europe, and Central Asia region face the highest levels of CVD mortality globally. Although CVD mortality levels are generally lower in women than men, this is not true in almost 30% of countries in the North Africa and Middle East and Sub-Saharan regions. Raised blood pressure remains the leading global CVD risk factor, contributing to 10.8 million deaths in 2019. The regions with the highest proportion of countries achieving the maximum score for the WHF Policy Index were South Asia, Central Europe, Eastern Europe, and Central Asia, and the High-Income regions. The Sub-Saharan Africa region had the highest proportion of countries scoring two or less. Policymakers must assess their country’s risk factor profile to craft effective strategies for CVD prevention and management. Fundamental strategies such as the implementation of National Tobacco Control Programmes, ensuring the availability of CVD medications, and establishing specialised units within health ministries to tackle non-communicable diseases should be embraced in all countries. Adequate healthcare system funding is equally vital, ensuring reasonable access to care for all communities. INTRODUCTION Cardiovascular diseases (CVDs) are the leading cause of mortality globally, responsible for a significant number of deaths and disabilities. In 2021 alone, CVDs accounted for 20.5 million deaths, comprising approximately one-third of all global deaths [1]. While cardiovascular conditions were traditionally considered diseases of affluence, this is no longer the case. Over three-quarters of CVD-related deaths occur in low- and middle-income countries (LMICs) [2]. Moreover, these deaths are the primary contributor to premature non-communicable disease (NCD) mortality. Ischemic heart disease, specifically, stands as the leading cause of premature death in 146 countries for men and 98 countries for women [3]. The complexity of the global picture is exacerbated by the levels of inequalities in the impact of CVDs. Notably, LMICs experience higher rates of premature mortality from CVDs compared to high-income countries (HICs), while the reduction in age-standardised mortality rates is progressing more slowly in LMICs. In May 2012 the World Health Assembly adopted the target of a 25% reduction in premature mortality from noncommunicable diseases by 2025. In May 2013 the NCD Global Monitoring Framework was launched during the World Health Assembly. Its primary objectives were to drive progress in the prevention and control of NCDs, serve as a foundation for advocacy, raise awareness, strengthen political commitment, and promote global action against NCDs. The framework encompassed nine voluntary global targets focused on behavioural and metabolic risk factors, as well as national healthcare system responses [4]. Over a decade has passed since international organisations and governments have been working towards achieving these global targets and reducing premature mortality. However, the current pace of decline is insufficient. Based on trends observed between 2010 and 2016, it is estimated that less than 20% of countries will achieve the UN Sustainable Development Goal Target 3.4 (SDG 3.4) – a one-third reduction in premature mortality from NCDs by 2030 [5]. Most countries, particularly those classified as low- or lower-middle income, need to accelerate progress to meet these targets. This paper summarises the World Heart Report 2023,1 which is a comprehensive overview of the trends and current landscape of the key dimensions of cardiovascular health. By synthesising epidemiological, policy, and economic data, the World Heart Report provides information that can help guide policymakers at national and international levels in identifying and addressing the most critical priorities to address cardiovascular conditions. METHODS AND DATA The analysis of the burden of cardiovascular diseases and associated risk in this study utilised data from global initiatives including the Global Burden of Disease Study [6], the NCD Risk Factor Collaboration [7], and the NCD Countdown 2030 initiative [3]. These have been extensively described elsewhere and are considered the most valid and reliable sources for global cardiovascular data. In selecting data sources, priority was given to those that offered a high level of disaggregation (by sex, age, country, region), data completeness, richness of the raw data informing the model, and comparability of estimates. Absolute numbers of death, age-standardised death rates, and the probability of dying between 30 and 70 years of age2 have been reported to describe the burden of cardiovascular mortality. Analysis of risk factors focused on nine specific factors. These factors were selected based on the six risk factors outlined in the WHO NCD Global Monitoring Framework, along with two additional risk factors—non-HDL cholesterol levels and air pollution. The inclusion of these two additional factors was based on their substantial impact on the prevalence and mortality rates of CVDs (Table 1). [Table: Mortality and risk factors indicators, source, and year.] To assess the risk factors’ country profiles, each country was ranked based on the level of the specific risk factor, ranging from the highest level to the lowest level. Subsequently, quintiles were generated for each risk factor, dividing the countries into five equal groups based on their respective levels of the risk factor. To assess the association between CVD burden and health expenditure, additional data on Gross Domestic Product (GDP), Current Health Expenditure as a percentage of GDP (CHE), and Out of Pocket Expenditure (OOPS) were obtained from the WHO Global Health Expenditure database [8]. The World Heart Federation Policy Index (WHF Policy Index) provides an overview of national governments’ level of implementation of eight critical policies related to CVD health (Table 2). The expert panel of the WHF Advocacy Committee carefully selected these policy indicators as the most relevant for ensuring a healthy heart profile in populations. Data for the WHF Policy Index were obtained from the Global Health Observatory [9]. Each policy was assigned a score of 0 if it was not in place in the country and 1 if it was in place. The overall index score for each country ranged from 0 (no policies in place) to 8 (all policies in place). Complete information was available for 166 countries. [Table: Policy indicators, source, and year.] Trends and levels are presented for both regions and individual countries. Countries were classified into regions based on the Global Burden of Diseases classification, which includes Central Europe, Eastern Europe, Central Asia, and the High-Income region as distinct regions (https://www.healthdata.org/sites/default/files/files/Projects/GBD/GBDRegions_countries.pdf). This division into more regions allows for more detailed comparisons of mortality and risk factor rates across significant geographical areas. To assess the association between CVD burden and health expenditure indicators the Pearson’s correlation coefficient was used. RESULTS The number of deaths due to acronym introduced in the introduction CVDs has increased over the years. In 1990, the estimated deaths stood at around 12.1 million [95% Uncertainty Interval: 11.4–12.6

Read the complete text